Mini Review - (2015) Volume 4, Issue 2

Pharmacological Inhibition of Phosholipase A2: Results from Phase 3 Clinical Trials with Darapladib and Varespladib in Patients with Cardiovascular Disease

Nicola Ferri1,2*, Chiara Ricci1 and Alberto Corsini1,2
1Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Italy, E-mail: nicola.ferri@unimi.it
2IRCCS, Multimedia, Milan, Italy, E-mail: nicola.ferri@unimi.it
*Corresponding Author: